IMPROVE 2022 International Meeting on Pathway‐Related Obesity : Vision of Excellence
Clinical Obesity · 2024
DOI: 10.1111/cob.12659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Obesity, 2024. Verfasst von Peter Kühnen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology and Diabetology, Charité Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Obesity, Receptor, Melanocortin, Type 4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Rhythm Pharmaceuticals.
Abstract (Originalsprache)
Nearly 90 clinicians and researchers from around the world attended the first IMPROVE 2022 International Meeting on Pathway‐Related Obesity. Delegates attended in person or online from across Europe, Argentina and Israel to hear the latest scientific and clinical developments in hyperphagia and severe, early‐onset obesity, and set out a vision of excellence for the future for improving the diagnosis, treatment, and care of patients with melanocortin‐4 receptor (MC4R) pathway‐related obesity. The meeting co‐chair Peter Kühnen, Charité Universitätsmedizin Berlin, Germany, indicated that change was needed with the rapidly increasing prevalence of obesity and the associated complications to improve the understanding of the underlying mechanisms and acknowledge that monogenic forms of obesity can play an important role, providing insights that can be applied to a wider group of patients with obesity. World‐leading experts presented the latest research and led discussions on the underlying science of obesity, diagnosis (including clinical and genetic approaches such as the role of defective MC4R signalling), and emerging clinical data and research with targeted pharmacological approaches. The aim of the meeting was to agree on the questions that needed to be addressed in future research and to ensure that optimised diagnostic work‐up was used with new genetic testing tools becoming available. This should aid the planning of new evidence‐based treatment strategies for the future, as explained by co‐chair Martin Wabitsch, Ulm University Medical Center, Germany.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology and Diabetology, Charité Universitätsmedizin Berlin, Berlin, Germany.
- Departments of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
- Assistance Publique-Hôpitaux de Paris, Nutrition Department, Pitié-Salpêtrière Hospital, Paris, France.
- INSERM, Nutrition and Obesity: Systemic Approaches, NutriOmics, Research Unit, Sorbonne Université, Paris, France.
- CARGO and Department of Medical Genetics, University of Strasbourg, Strasbourg, France.
- Sorbonne Université, Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
ORCID-Profile: Béatrice Dubern, Lotte Kleinendorst
Förderung
- Rhythm Pharmaceuticals
Zitieren
APA
Kühnen, P., Argente, J., Clément, K., Dollfus, H., Dubern, B., Farooqi, S., de Groot, C., Grüters, A., Holm, J. C., Hopkins, M., Kleinendorst, L., Körner, A., Meeker, D., Rydén, M., von Schnurbein, J., Tschöp, M., Yeo, G. S. H., Zorn, S., & Wabitsch, M. (2024). IMPROVE 2022 International Meeting on Pathway‐Related Obesity : Vision of Excellence. Clinical Obesity. https://doi.org/10.1111/cob.12659
Vancouver
Kühnen P, Argente J, Clément K, Dollfus H, Dubern B, Farooqi S, et al. IMPROVE 2022 International Meeting on Pathway‐Related Obesity : Vision of Excellence. Clinical Obesity. 2024. doi:10.1111/cob.12659
BibTeX
@article{Khnen2024,
author = {Kühnen, Peter and Argente, Jesús and Clément, Karine and Dollfus, Hélène and Dubern, Béatrice and Farooqi, Sadaf and de Groot, Corjan and Grüters, Annette and Holm, Jens-Christian and Hopkins, Mark and Kleinendorst, Lotte and Körner, Antje and Meeker, David and Rydén, Mikael and von Schnurbein, Julia and Tschöp, Matthias and Yeo, Giles S H and Zorn, Stefanie and Wabitsch, Martin},
title = {IMPROVE 2022 International Meeting on Pathway‐Related Obesity : Vision of Excellence},
journal = {Clinical Obesity},
year = {2024},
doi = {10.1111/cob.12659}
}
EUVIMED